Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: A multicenter study

American Journal of Hematology

Volumn 86, Issue 3, 2011, Pages 256-261

  Castillo, Jorge J ^a   Beltran, Brady E ^b   Bibas, Michele ^c   Bower, Mark ^d   Collins, Jaime A ^e   Cwynarski, Kate ^f   Diez Martin, Jose L ^g   Hernandez Ilizaliturri, Francisco ^h   Horwitz, Steven M ⁱ   Montoto, Silvia ^j   Pantanowitz, Liron ^k,n   Ribera, Josep Maria ^l   Vose, Julie M ^m  

^a BROWN UNIVERSITY   (United States)

^b HOSPITAL NACIONAL EDGARDO REBAGLIATI MARTINS   (Peru)

^c NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^d CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^e HOSPITAL NACIONAL GUILLERMO ALMENARA IRIGOYEN   (Peru)

^f ROYAL FREE HOSPITAL   (United Kingdom)

^g HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^h ROSWELL PARK CANCER INSTITUTE   (United States)

ⁱ MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^j ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^k BAYSTATE MEDICAL CENTER   (United States)

^l HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^m UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

ⁿ UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHYLPREDNISOLONE; PREDNISONE; VINBLASTINE; VINCRISTINE; VINDESINE;

ADOLESCENT; ADULT; ANGIOIMMUNOBLASTIC LYMPHOMA; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CD4+ T LYMPHOCYTE; DISEASE SEVERITY; ENTEROPATHY TYPE T CELL LYMPHOMA; FEMALE; HEPATOSPLENIC T CELL LYMPHOMA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LARGE CELL LYMPHOMA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANNICULITIS LIKE T CELL LYMPHOMA; PERIPHERAL T CELL LYMPHOMA; PERIPHERAL T CELL LYMPHOMA UNSPECIFIED; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SEX RATIO; SURVIVAL TIME; VIRUS LOAD;

ADOLESCENT; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; FEMALE; HUMANS; LYMPHOMA, AIDS-RELATED; LYMPHOMA, T-CELL, PERIPHERAL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; VIRAL LOAD; YOUNG ADULT;

EID: 79951909855     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21947     Document Type: Article

References (40)

1. Levine AM, Seneviratne L, Espina BM, et al. Evolving characteristics of AIDS-related lymphoma. Blood 2000; 96: 4084-4090.
2. Cote TR, Biggar RJ, Rosenberg PS, et al. Non-Hodgkin's lymphoma among people with AIDS: Incidence, presentation and public health burden. AIDS/Cancer Study Group. Int J Cancer 1997; 73: 645-650.
3. Biggar RJ, Engels EA, Frisch M, Goedert JJ. Risk of T-cell lymphomas in persons with AIDS. J Acquir Immune Defic Syndr 2001; 26: 371-376.
4. Chadburn A, Cesarman E, Jagirdar J, et al. CD30 (Ki-1) positive anaplastic large cell lymphomas in individuals infected with the human immunodeficiency virus. Cancer 1993; 72: 3078-3090.
5. Gold JE, Ghali V, Gold S, et al. Angiocentric immunoproliferative lesion/T-cell non-Hodgkin's lymphoma and the acquired immune deficiency syndrome: A case report and review of the literature. Cancer 1990; 66: 2407-2413.
6. Gonzalez-Clemente JM, Ribera JM, Campo E, et al. Ki-1+ anaplastic large-cell lymphoma of T-cell origin in an HIV-infected patient. Aids 1991; 5: 751-755.
7. Herndier BG, Shiramizu BT, Jewett NE, et al. Acquired immunodeficiency syndrome-associated T-cell lymphoma: Evidence for human immunodeficiency virus type 1-associated T-cell transformation. Blood 1992; 79: 1768-1774.
8. Kobayashi M, Yoshimoto S, Fujishita M, et al. HTLV-positive T-cell lymphoma/leukaemia in an AIDS patient. Lancet 1984; 1: 1361-1362.
9. Nasr SA, Brynes RK, Garrison CP, Chan WC. Peripheral T-cell lymphoma in a patient with acquired immune deficiency syndrome. Cancer 1988; 61: 947-951.
10. Pantanowitz L, Castillo J, Freeman JK, Dezube BJ. Images in HIV/AIDS. Fatal HIV-associated anaplastic large-cell lymphoma. AIDS Read 2009; 19: 19-21.
11. Proca DM, De Renne L, Marsh WLJr, Keyhani-Rofagha S. Anaplastic large cell lymphoma in a human immunodeficiency virus-positive patient with cytologic findings in bladder wash: A case report. Acta Cytol 2008; 52: 83-86.
12. Shibata D, Brynes RK, Rabinowitz A, et al. Human T-cell lymphotropic virus type I (HTLV-I)-associated adult T-cell leukemia-lymphoma in a patient infected with human immunodeficiency virus type 1 (HIV-1). Ann Intern Med 1989; 111: 871-875.
13. Tisdale G, Mahadevan A, Matthews RH. T-cell lymphoma of the rectum in a patient with AIDS and hepatitis C: A case report and discussion. Oncologist 2005; 10: 292-298.
14. Arzoo KK, Bu X, Espina BM, et al. T-cell lymphoma in HIV-infected patients. J Acquir Immune Defic Syndr 2004; 36: 1020-1027.
15. Brimo F, Michel RP, Khetani K, Auger M. Primary effusion lymphoma: A series of 4 cases and review of the literature with emphasis on cytomorphologic and immunocytochemical differential diagnosis. Cancer 2007; 111: 224-233.
16. Collins JA, Hernandez AV, Hidalgo JA, et al. High proportion of T-cell systemic non-Hodgkin lymphoma in HIV-infected patients in Lima, Peru. J Acquir Immune Defic Syndr 2005; 40: 558-564.
17. Nava VE, Cohen P, Kalan M, Ozdemirli M. HIV-associated anaplastic large cell lymphoma: A report of three cases. Aids 2008; 22: 1892-1894.
18. Castillo J, Perez K, Milani C, et al. Peripheral T-cell lymphomas in HIV-infected individuals: A comprehensive review. J HIV Ther 2009; 14: 34-40.
19. Swerdlow S, Campo E, Harris N, et al. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues, 4th ed. Lyon, France: International Agency for Research on Cancer; 2008.
20. A predictive model for aggressive non-Hodgkin's lymphoma. The international non-Hodgkin's lymphoma prognostic factors project. N Engl J Med 1993; 329: 987-994.
21. Gallamini A, Stelitano C, Calvi R, et al. Peripheral T-cell lymphoma unspecified (PTCL-U): A new prognostic model from a retrospective multicentric clinical study. Blood 2004; 103: 2474-2479.
22. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
23. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-170.
24. Cox DR. Regression models and life-tables. J R Stat Soc 1982; 34: 187-220.
25. Vose J, Armitage J, Weisenburger D. International peripheral T-cell and natural killer/T-cell lymphoma study: Pathology findings and clinical outcomes. J Clin Oncol 2008; 26: 4124-4130.
26. Tanaka PY, Pracchia LF, Bellesso M, et al. A prognostic score for AIDS-related diffuse large B-cell lymphoma in Brazil. Ann Hematol 2009. Jun 4 [Epub ahead of print].
27. Castillo J, Pantanowitz L, Dezube BJ. HIV-associated plasmablastic lymphoma: Lessons learned from 112 published cases. Am J Hematol 2008; 83: 804-809.
28. Levine AM. Acquired immunodeficiency syndrome-related lymphoma. Blood 1992; 80: 8-20.
29. Savage KJ, Harris NL, Vose JM, et al. ALK-anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: Report from the international peripheral t-cell lymphoma project. Blood 2008; 111: 5496-5504.
30. Perez K, Castillo J, Dezube BJ, Pantanowitz L. Human immunodeficiency virus-associated anaplastic large cell lymphoma. Leuk Lymph 2010; 51: 430-438.
31. Aozasa K, Takakuwa T, Hongyo T, Yang WI. Nasal NK/T-cell lymphoma: Epidemiology and pathogenesis. Int J Hematol 2008; 87: 110-117.
32. Dupuis J, Emile JF, Mounier N, et al. Prognostic significance of Epstein-Barr virus in nodal peripheral T-cell lymphoma, unspecified: A Groupe d'Etude des Lymphomes de l'Adulte (GELA) study. Blood 2006; 108: 4163-4169.
33. Herling M, Rassidakis GZ, Jones D, et al. Absence of Epstein-Barr virus in anaplastic large cell lymphoma: A study of 64 cases classified according to World Health Organization criteria. Hum Pathol 2004; 35: 455-459.
34. Diez-Martin JL, Balsalobre P, Re A, et al. Comparable survival between HIV+ and HIV- non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation. Blood 2009; 113: 6011-6014.
35. Lim ST, Karim R, Tulpule A, et al. Prognostic factors in HIV-related diffuse large-cell lymphoma: Before versus after highly active antiretroviral therapy. J Clin Oncol 2005; 23: 8477-8482.
36. Simcock M, Blasko M, Karrer U, et al. Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: Findings from the Swiss HIV Cohort Study. Antivir Ther 2007; 12: 931-939.
37. Miralles P, Berenguer J, Ribera JM, et al. Prognosis of AIDS-related systemic non-Hodgkin lymphoma treated with chemotherapy and highly active antiretroviral therapy depends exclusively on tumor-related factors. J Acquir Immune Defic Syndr 2007; 44: 167-173.
38. Mounier N, Spina M, Gabarre J, et al. AIDS-related non-Hodgkin lymphoma: Final analysis of 485 patients treated with risk-adapted intensive chemotherapy. Blood 2006; 107: 3832-3840.
39. Ribera JM, Navarro JT. Human immunodeficiency virus-related non-Hodgkin's lymphoma. Haematologica 2008; 93: 1129-1132.
40. Hoffmann C, Wolf E, Fatkenheuer G, et al. Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma. Aids 2003; 17: 1521-1529.